Gilead Sciences (United States)
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Gilead Sciences (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
59%
Total
Publications
5.6K
Total Open
Publications
3.3K
Total
Citations
246K
Open Access
Percentage
59%
Total
Publications
5.6K
Total Open
Publications
3.3K
Total
Citations
246K
Breakdown
Publisher Open
22%
Both
25%
Other Platform Open
12%
Closed
41%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 31%
800
Hybrid 33%
866
No Guarantees 36%
945
Other Platform Open
Domain 87%
1.8K
Institution 22%
456
Other Internet 10%
196
Public 7%
136
Preprint 6%
126
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 1.8K |
Europe PMC | Domain | 925 |
Semantic Scholar | Public | 111 |
DOI | Other Internet | 105 |
University of California - eScholarship University of California | Institution | 73 |
California Digital Library - eScholarship | Other Internet | 64 |
University of North Carolina at Chapel Hill - Carolina Digital Repository | Institution | 55 |
bioRxiv | Preprint | 55 |
University College London - UCL Discovery | Institution | 53 |
Figshare | Public | 37 |